NO20052814D0 - Cytomodulerende peptider for behandling av interstitielle cystitt - Google Patents
Cytomodulerende peptider for behandling av interstitielle cystittInfo
- Publication number
- NO20052814D0 NO20052814D0 NO20052814A NO20052814A NO20052814D0 NO 20052814 D0 NO20052814 D0 NO 20052814D0 NO 20052814 A NO20052814 A NO 20052814A NO 20052814 A NO20052814 A NO 20052814A NO 20052814 D0 NO20052814 D0 NO 20052814D0
- Authority
- NO
- Norway
- Prior art keywords
- cytomodulatory
- peptides
- treatment
- interstitial cystitis
- cystitis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/046—Tachykinins, e.g. eledoisins, substance P; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42668402P | 2002-11-15 | 2002-11-15 | |
| US47083903P | 2003-05-15 | 2003-05-15 | |
| PCT/US2003/037043 WO2004045554A2 (en) | 2002-11-15 | 2003-11-17 | Cytomodulating peptides for treating interstitial cystitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052814D0 true NO20052814D0 (no) | 2005-06-10 |
| NO20052814L NO20052814L (no) | 2005-08-04 |
Family
ID=32329122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052814A NO20052814L (no) | 2002-11-15 | 2005-06-10 | Cytomodulerende peptider for behandling av interstitielle cystitt |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7671026B2 (no) |
| EP (1) | EP1594519A4 (no) |
| JP (1) | JP2006516546A (no) |
| KR (1) | KR20050086676A (no) |
| AU (1) | AU2003294357A1 (no) |
| BR (1) | BR0316290A (no) |
| CA (1) | CA2505922A1 (no) |
| CO (1) | CO5640064A2 (no) |
| MA (1) | MA27607A1 (no) |
| MX (1) | MXPA05005101A (no) |
| NO (1) | NO20052814L (no) |
| RU (1) | RU2005118425A (no) |
| WO (1) | WO2004045554A2 (no) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008014484A1 (en) * | 2006-07-27 | 2008-01-31 | University Of Maryland, Baltimore | Cellular receptor for antiproliferative factor |
| BRPI0906404B8 (pt) * | 2008-01-24 | 2021-05-25 | Univ Louisiana State | construção de fusão com domínio lítico, seus usos, composição farmacêutica, bem como processo para reduzir ou inibir seletivamente a proliferação de uma célula que expressa um receptor, ligante ou antígeno |
| US8912146B2 (en) | 2008-08-18 | 2014-12-16 | University Of Maryland, Baltimore | Derivatives of APF and methods of use |
| WO2012048721A1 (en) | 2010-10-14 | 2012-04-19 | Xigen S.A. | Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases |
| CA2915960A1 (en) | 2013-06-17 | 2014-12-24 | Asana Biosciences, Llc | 5t4-targeted immunofusion molecule and methods |
| WO2014206426A1 (en) * | 2013-06-26 | 2014-12-31 | Xigen Inflammation Ltd. | New use for jnk inhibitor molecules for treatment of various diseases |
| WO2015197097A1 (en) | 2014-06-26 | 2015-12-30 | Xigen Inflammation Ltd. | New use for jnk inhibitor molecules for treatment of various diseases |
| WO2014206427A1 (en) | 2013-06-26 | 2014-12-31 | Xigen Inflammation Ltd. | New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| CA2947508A1 (en) * | 2014-06-26 | 2015-12-30 | Xigen Inflammation Ltd. | New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| US10859579B2 (en) * | 2016-03-31 | 2020-12-08 | William Beaumont Hospital | Methods for detecting, diagnosing and treating ulcerative interstitial cystitis |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR199902786T2 (xx) * | 1997-04-11 | 2000-06-21 | Sangstat Medical Corporation | Ba����kl�k sistemi faaliyetinin d�zene sokulmas� ve iltihaplanman�n durdurulmas� i�in lipofilik peptidlerin h�cre yap�s�n�n d�zene konulmas�. |
| US6696545B1 (en) * | 1997-04-11 | 2004-02-24 | Sangstat Medical Corporation | Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| JP2002512259A (ja) * | 1998-04-17 | 2002-04-23 | ユニバーシティ・オブ・メリーランド， ボルティモア | 組換えヘパリン結合性上皮成長因子様成長因子（ｈｂ−ｅｇｆ）による間質性膀胱炎の治療方法 |
| MXPA05003063A (es) * | 2002-09-20 | 2005-05-27 | Alcon Inc | Uso de inhibidores de la sintesis de citosina para el tratamiento de trastornos de ojos secos. |
-
2003
- 2003-11-17 CA CA002505922A patent/CA2505922A1/en not_active Abandoned
- 2003-11-17 WO PCT/US2003/037043 patent/WO2004045554A2/en active Application Filing
- 2003-11-17 JP JP2004570638A patent/JP2006516546A/ja active Pending
- 2003-11-17 KR KR1020057008774A patent/KR20050086676A/ko not_active Application Discontinuation
- 2003-11-17 AU AU2003294357A patent/AU2003294357A1/en not_active Abandoned
- 2003-11-17 BR BR0316290-7A patent/BR0316290A/pt not_active Application Discontinuation
- 2003-11-17 EP EP03789840A patent/EP1594519A4/en not_active Ceased
- 2003-11-17 MX MXPA05005101A patent/MXPA05005101A/es not_active Application Discontinuation
- 2003-11-17 RU RU2005118425/14A patent/RU2005118425A/ru not_active Application Discontinuation
- 2003-11-17 US US10/535,167 patent/US7671026B2/en not_active Expired - Fee Related
-
2005
- 2005-06-10 NO NO20052814A patent/NO20052814L/no unknown
- 2005-06-14 CO CO05057644A patent/CO5640064A2/es not_active Application Discontinuation
- 2005-06-14 MA MA28336A patent/MA27607A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO5640064A2 (es) | 2006-05-31 |
| US20060194738A1 (en) | 2006-08-31 |
| EP1594519A4 (en) | 2006-08-16 |
| KR20050086676A (ko) | 2005-08-30 |
| AU2003294357A1 (en) | 2004-06-15 |
| WO2004045554A2 (en) | 2004-06-03 |
| EP1594519A2 (en) | 2005-11-16 |
| US7671026B2 (en) | 2010-03-02 |
| WO2004045554A3 (en) | 2005-07-07 |
| RU2005118425A (ru) | 2006-02-10 |
| NO20052814L (no) | 2005-08-04 |
| CA2505922A1 (en) | 2004-06-03 |
| JP2006516546A (ja) | 2006-07-06 |
| MXPA05005101A (es) | 2005-09-08 |
| MA27607A1 (fr) | 2005-11-01 |
| BR0316290A (pt) | 2005-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052894D0 (no) | 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte | |
| NO20053041D0 (no) | Behandling av diabetes. | |
| NO20052814D0 (no) | Cytomodulerende peptider for behandling av interstitielle cystitt | |
| NO20052058D0 (no) | Behandling av influensa. | |
| DK1944322T3 (da) | Behandling af TNFalfa-relaterede sygdomme | |
| NO20053077D0 (no) | Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer. | |
| DE60336485D1 (de) | Kombinationstherapie gegen hyperproliferative erkrankungen | |
| NO20052914D0 (no) | Terapeutiske forbindelser | |
| FI20060154A (fi) | Neurogeneratiivisten tilojen hoito | |
| DE60333537D1 (de) | Herzschrittmacher | |
| DE50203563D1 (de) | Rollosystem | |
| EA200500098A1 (ru) | Лекарственное средство и способ лечения патологического синдрома | |
| DE60311298D1 (de) | Kopfhautbehandlung | |
| NO20045554L (no) | Fremgangsmate for behandling av diabetes | |
| IS7825A (is) | Meðferðarfræðileg meðhöndlun | |
| NO20033804L (no) | Karbamatforbindelser for behandling av smerte | |
| DE60326190D1 (de) | des Körpers | |
| ATE442835T1 (de) | Oberflächenbehandlung | |
| DK1687297T3 (da) | Triazindimerer til behandling af autoimmunsygdomme | |
| NO20043445L (no) | Kombinasjonsterapi for behandling av bakterielle infeksjoner | |
| NO20040497L (no) | Amidinderivater for behandling av amyloidose | |
| DE602004030779D1 (de) | Angehen des problems des schrittmachersyndroms | |
| DE60322942D1 (de) | Textilbehandlung | |
| ATE359270T1 (de) | Phenyl-piperidin-4-yliden-methyl-benzamidderiva e zur behandlung von schmerz oder magen-darm- erkrankungen | |
| DK1567524T3 (da) | Thia-epothilonderivater til behandling af cancer |